What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
His primary areas of investigation include Sickle cell anemia, Internal medicine, Anemia, Hemoglobinopathy and Surgery.
His study in Sickle cell anemia is interdisciplinary in nature, drawing from both Hemolytic anemia, Transfusion therapy, Pediatrics and Stroke.
The concepts of his Pediatrics study are interwoven with issues in Mortality rate, Epidemiology and Cohort study.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Cardiology, Gastroenterology, Immunology and Pathology.
His Anemia research integrates issues from Randomized controlled trial, Disease, Hemoglobin SC Disease, Blood transfusion and Transplantation.
In his work, Adverse effect, ABO blood group system, Alpha-thalassemia and Ineffective erythropoiesis is strongly intertwined with Thalassemia, which is a subfield of Hemoglobinopathy.
His most cited work include:
- Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography (1388 citations)
- Pain in sickle cell disease. Rates and risk factors. (1249 citations)
- Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. (875 citations)
What are the main themes of his work throughout his whole career to date?
Elliott Vichinsky mainly focuses on Internal medicine, Sickle cell anemia, Thalassemia, Pediatrics and Disease.
His research in Internal medicine is mostly concerned with Anemia.
The Anemia study combines topics in areas such as Randomized controlled trial and Blood transfusion.
His Sickle cell anemia study incorporates themes from Hemolytic anemia, Hemoglobinopathy, Surgery and Stroke.
His work on Newborn screening as part of general Pediatrics research is often related to In patient, thus linking different fields of science.
His studies deal with areas such as Cell, Pharmacology and Intensive care medicine as well as Disease.
He most often published in these fields:
- Internal medicine (54.53%)
- Sickle cell anemia (36.22%)
- Thalassemia (31.98%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (54.53%)
- Thalassemia (31.98%)
- Disease (26.59%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Thalassemia, Disease, Pediatrics and Anemia.
His Internal medicine research includes themes of Gastroenterology and Endocrinology.
His work on Acute chest syndrome as part of general Disease study is frequently connected to Hope trial, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Elliott Vichinsky interconnects Observational study, Sickle cell anemia, Epidemiology, Hydrops fetalis and Hemosiderosis in the investigation of issues within Pediatrics.
His Sickle cell anemia research incorporates elements of Hemolytic anemia and Surrogate endpoint.
His Anemia study also includes
- Immunology, which have a strong connection to Transplantation and Beta thalassemia,
- Randomized controlled trial which intersects with area such as Placebo-controlled study.
Between 2012 and 2021, his most popular works were:
- Sickle cell disease (248 citations)
- Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia (239 citations)
- A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. (150 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Elliott Vichinsky mainly investigates Internal medicine, Thalassemia, Disease, Pediatrics and Transplantation.
In Internal medicine, Elliott Vichinsky works on issues like Gastroenterology, which are connected to Surgery.
Elliott Vichinsky has researched Thalassemia in several fields, including Young adult, Hematology, Non transfusion dependent thalassemia and Pathology.
His Hematology study combines topics from a wide range of disciplines, such as Silent stroke and Sickle cell anemia.
His research integrates issues of Cell, Health care, Anemia, Newborn screening and Intensive care medicine in his study of Disease.
His studies in Anemia integrate themes in fields like Prospective cohort study and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
